Literature DB >> 19094925

[The challenges of the bone micro-architecture].

Mouna Rachidi1, Sophie Breban, Claude-Laurent Benhamou.   

Abstract

Osteoporosis is a bone disorder that leads to increased fracture risk. It was defined by the World Health Organisation as a decrease of bone mass and a deterioration of bone quality. In clinical practice, the diagnosis of osteoporosis is based on bone mineral density (BMD) measurements assessed by dual energy X-ray absorptiometry. However, BMD assessment is not the only factor that influences bone strength. The main objective is that clinicians can use a combination of risk factors that are easily assessable, for a better prediction of osteoporosis risk fracture. Bone strength reflects both bone density and bone quality. One of the most important determinants of bone quality is the trabecular bone micro-architecture as suggested by the definition of osteoporosis. Moreover, various studies have concluded to the potential clinical interest of the bone micro-architecture. The aim of this article was to review the challenges of bone micro-architecture, characterization tools (morphological analysis, topology, texture) and imaging techniques (X-ray imaging, scanning and MRI) to assess trabecular bone micro-architecture.

Entities:  

Mesh:

Year:  2008        PMID: 19094925     DOI: 10.1051/jbio:2008035

Source DB:  PubMed          Journal:  J Soc Biol        ISSN: 1295-0661


  2 in total

1.  MR imaging texture analysis of the corpus callosum and thalamus in amnestic mild cognitive impairment and mild Alzheimer disease.

Authors:  M S de Oliveira; M L F Balthazar; A D'Abreu; C L Yasuda; B P Damasceno; F Cendes; G Castellano
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-21       Impact factor: 3.825

2.  Chlorogenic Acid Prevents Osteoporosis by Shp2/PI3K/Akt Pathway in Ovariectomized Rats.

Authors:  Rong Ping Zhou; Si Jian Lin; Wen Bing Wan; Hui Ling Zuo; Fen Fen Yao; Hui Bing Ruan; Jin Xu; Wei Song; Yi Cheng Zhou; Shi Yao Wen; Jiang Hua Dai; Mei Lan Zhu; Jun Luo
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.